Recommendations Developed for Treating Hypercalcemia of Malignancy
December 30, 2022
Occurrence of Cardiovascular Events, Death Compared Between Thiazides
January 3, 2023Generic for Treanda - Bendamustine Hydrochloride Lyophilized Powder for Injection 25 mg/vial and 100 mg/vial
Treatment for: Chronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma
Approved: December 7, 2022 (Accord Healthcare Inc.)
Generic for Hetlioz - Tasimelteon Capsules 20 mg
Treatment for: Non-24-Hour Sleep Wake Disorder
Approved: December 12, 2022 (Teva Pharmaceuticals USA, Inc.)
Generic for Uptravi - Selexipag Tablets 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2 mg, 1.4 mg and 1.6 mg
Treatment for: Pulmonary Arterial Hypertension
Approved: December 21, 2022 (Zydus Pharmaceuticals USA Inc.)
Generic for Keveyis - Dichlorphenamide Tablets 50 mg
Treatment for: Hypokalemic Periodic Paralysis; Hyperkalemic Periodic Paralysis
Approved: December 29, 2022 (Torrent Pharma Inc.)